-15%
Veenat 400mg Tablet (Imatinib) is indicated for the treatment of various conditions in adults, children, and adolescents, including:
- Chronic Myeloid Leukaemia (CML)
- Philadelphia Chromosome Positive Acute Lymphoblastic Leukaemia (Ph-positive ALL)
Additionally, Veenat 400mg Tablet is used specifically in adults for the treatment of:
- Myelodysplastic/Myeloproliferative Diseases (MDS/MPD)
- Hyper-eosinophilic syndrome (HES) and/or Chronic Eosinophilic Leukaemia (CEL)
- Gastrointestinal Stromal Tumours (GIST)
- Dermatofibrosarcoma Protuberans (DFSP)
Veenat 400mg Tablet, containing Imatinib, a Tyrosine Kinase Inhibitor, is utilized to treat various conditions in adults, children, and adolescents, including:
- Chronic Myeloid Leukaemia (CML)
- Philadelphia Chromosome Positive Acute Lymphoblastic Leukaemia (Ph-positive ALL)
- Myelodysplastic/Myeloproliferative Diseases (MDS/MPD)
- Hyper Eosinophilic Syndrome (HES) and/or Chronic Eosinophilic Leukaemia (CEL)
- Gastrointestinal Stromal Tumours (GIST)
- Dermatofibrosarcoma Protuberans (DFSP)
Before initiating Veenat 400mg Tablet, disclose any history of kidney, liver, or heart issues, hepatitis B infection, or thrombotic microangiopathy to your doctor.
Pregnant and breastfeeding women should avoid VEENAT 400MG TABLET unless specifically advised by a physician. Caution is warranted in children, adolescents, and elderly individuals (aged 65 years and above).
